Activating Transcription Factor 3 regulates in part the enhanced tumour cell cytotoxicity of the histone deacetylase inhibitor M344 and cisplatin in combination

被引：0
|
作者：
Carly St Germain
Anna O'Brien
Jim Dimitroulakos
机构：
[1] Ottawa Hospital Research Institute,Centre for Cancer Therapeutics
[2] the University of Ottawa,Department of Medicine
[3] the University of Ottawa,Department of Biochemistry
来源：
Cancer Cell International | / 10卷
关键词：
ATF3 Expression; M344 Treatment; Integrate Stress Response; ATF3 Gene; ATF3 mRNA;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 7 条
  • [1] Activating Transcription Factor 3 regulates in part the enhanced tumour cell cytotoxicity of the histone deacetylase inhibitor M344 and cisplatin in combination
    St Germain, Carly
    O'Brien, Anna
    Dimitroulakos, Jim
    CANCER CELL INTERNATIONAL, 2010, 10
  • [2] Activating Transcription Factor 3 Expression as a Marker of Response to the Histone Deacetylase Inhibitor Pracinostat
    Sooraj, Dhanya
    Xu, Dakang
    Cain, Jason E.
    Gold, Daniel P.
    Williams, Bryan R. G.
    MOLECULAR CANCER THERAPEUTICS, 2016, 15 (07) : 1726 - 1739
  • [3] RETRACTED: M344 is a novel synthesized histone deacetylase inhibitor that induces growth inhibition, cell cycle arrest, and apoptosis in human endometrial cancer and ovarian cancer cells (Retracted Article)
    Takai, N
    Ueda, T
    Nishida, M
    Nasu, K
    Narahara, H
    GYNECOLOGIC ONCOLOGY, 2006, 101 (01) : 108 - 113
  • [4] M344 is a novel synthesized histone deacetylase inhibitor that induces growth inhibition, cell cycle arrest, and apoptosis in human endometrial cancer and ovarian cancer cells (Retraction of vol 101, pg 108, 2006)
    Takai, Noriyuki
    Ueda, Tami
    Nishida, Masakazu
    Nasu, Kaei
    Narahara, Hisashi
    GYNECOLOGIC ONCOLOGY, 2013, 129 (01) : 270 - 270
  • [5] Activating transcription factor 3 interferes with p21 activation in histone deacetylase inhibitor-induced growth inhibition of epidermoid carcinoma cells
    Hao, Zhen-Feng
    Su, You-Ming
    Wang, Cong-min
    Yang, Rong-Ya
    TUMOR BIOLOGY, 2015, 36 (03) : 1471 - 1476
  • [6] Transcription factor 3 (TCF3) combined with histone deacetylase 3 (HDAC3) down-regulates microRNA-101 to promote Burkitt lymphoma cell proliferation and inhibit apoptosis
    Dong, Lihua
    Huang, Jingjing
    Zu, Peng
    Liu, Jing
    Gao, Xue
    Du, Jianwei
    Li, Yufu
    BIOENGINEERED, 2021, 12 (01) : 7995 - 8005
  • [7] THE HISTONE DEACETYLASE INHIBITOR ROMIDEPSIN IN COMBINATION WITH LENALIDOMIDE ENHANCES CYTOTOXICITY VIA THE DOWN-REGULATION OF PI3K/AKT AND MAPK/ERK PATHWAYS IN T-CELL LYMPHOMA CELLS
    Sacchi, S.
    Cosenza, M.
    Civallero, M.
    Pozzi, S.
    Fiorcari, S.
    Marcheselli, L.
    HAEMATOLOGICA, 2014, 99 : 688 - 688
1